MMB8006 : Drug Discovery and Development
MMB8006 : Drug Discovery and Development
- Offered for Year: 2024/25
- Module Leader(s): Dr Simon Hill
- Lecturer: Dr Ruben Thanacoody, Prof. Simon Thomas, Professor Ruth Plummer, Dr Ian Hardcastle, Dr Adam Potts, Dr Simon Wilkinson, Dr Matthew Leach
- Owning School: Biomedical, Nutritional and Sports Scien
- Teaching Location: Newcastle City Campus
Semesters
Your programme is made up of credits, the total differs on programme to programme.
Semester 1 Credit Value: | 20 |
ECTS Credits: | 10.0 |
European Credit Transfer System | |
Pre-requisite
Modules you must have done previously to study this module
Pre Requisite Comment
None
Co-Requisite
Modules you need to take at the same time
Code | Title |
---|---|
MMB8005 | Experimental Medicine & Therapeutics |
Co Requisite Comment
Students wishing to graduate in MRes Translational Medicine & Therapeutics must undertake this module and the module MMB8005 (Experimental Medicine & Therapeutics.
All other MRes students may enrol on this module if they wish - timetable permitting
Aims
To develop a cohort of learners who have a detailed and practical understanding of the drug discovery and development process and the necessary actions needed to take a basic science concept and translate it into a first in man study of a potential drug. To situate the learning within UK regulatory and the research governance framework.
Outline Of Syllabus
The module covers the following topics, delivered through a series of lectures and formative assessments delivered through e-learning, supported by weekly interactive face-to-face seminars.
Pharmacokinetics (Drug absorption, distribution, metabolism and elimination)
Pharmacodynamics (Mechanisms of drug action)
Pharmacogenomics and Inter-individual variability in pharmacokinetics and drug effects
Targets and target validation
Screening and hits
Molecular biology underpinning drug discovery
Optimising molecules
Pre-clinical studies
Toxicology
Clinical Trial Authorisation / First-in-man studies
Learning Outcomes
Intended Knowledge Outcomes
By the end of the module students should be able to:
• Describe the drug discovery and development process and it’s place in the research governance framework
• Evaluate and critically appraise the effectiveness of the drug discovery and development process and suggest reasons for the number of new drugs to market being less than expected
• Summarise the methods used to identify and validate drug targets
• Discuss the screening of compounds for activity against targets
• Give an overview of the various stages of optimisation that a hit must go through to eventually become a clinical candidate
• Describe the pre-clinical assessments required for clinical trial authorisation
• Summarise the clinical phases of drug development
Intended Skill Outcomes
By the end of the module students should be able to:
• Summarise the required information and evidence needed to populate the application to the MHRA for a Clinical Trial Authorisation
• Interact effectively with academic and industrial colleagues working on drug discovery and development projects
• Critically appraise pre-clinical data ahead of regulatory submission and suggest whether the candidate molecule should proceed to clinical studies
Teaching Methods
Teaching Activities
Category | Activity | Number | Length | Student Hours | Comment |
---|---|---|---|---|---|
Guided Independent Study | Assessment preparation and completion | 1 | 84:30 | 84:30 | Preparation of in-course assessment |
Guided Independent Study | Directed research and reading | 12 | 8:00 | 96:00 | E-learning sessions, to be completed in specified weeks preceding scheduled seminars |
Scheduled Learning And Teaching Activities | Small group teaching | 2 | 1:00 | 2:00 | Present in person (PIP) Pharmacology seminar |
Scheduled Learning And Teaching Activities | Small group teaching | 7 | 2:00 | 14:00 | Present in person (PIP) Drug Discovery problem based small group work seminars |
Scheduled Learning And Teaching Activities | Small group teaching | 1 | 1:00 | 1:00 | Present in person (PIP): First in man |
Scheduled Learning And Teaching Activities | Drop-in/surgery | 1 | 0:30 | 0:30 | Present in person (PIP): in-course assessment preparation |
Scheduled Learning And Teaching Activities | Module talk | 2 | 1:00 | 2:00 | Present in person (PIIP) Introductory sessions |
Total | 200:00 |
Teaching Rationale And Relationship
This module is taught by a flipped classroom approach in conjunction with the Pharmaceutical Industry.
Core theoretical content will be provided by e-learning via Canvas and will provide a framework on which to construct further learning. Weekly interactive seminars will involve collaborative, problem based activities and tasks that will encourage students to activate and build on the previous week’s learning and facilitate deeper learning through social interaction - this key module feature is to allow learners to develop practical knowledge, skills and attitudes that can be applied in practice and future careers. Seminars also provide an opportunity to develop other skills including interpersonal and oral communication, collaboration and information literacy.
Private study is used for self-directed learning including further reading, preparation for the seminars, undertaking a piece of written coursework and preparing for examinations. This will allow the learners to develop skills in locating and appraising appropriate literature.
Reading Lists
Assessment Methods
The format of resits will be determined by the Board of Examiners
Other Assessment
Description | Semester | When Set | Percentage | Comment |
---|---|---|---|---|
Report | 1 | M | 50 | Written report 1000 words Flow chart expected/proposed screening cascade & optimization strategy for chosen drug target/equivalent |
Report | 1 | M | 50 | Written report 1000 words. Submission of tox and whole animal pharmacology strategy for a fixed project. |
Formative Assessments
Formative Assessment is an assessment which develops your skills in being assessed, allows for you to receive feedback, and prepares you for being assessed. However, it does not count to your final mark.
Description | Semester | When Set | Comment |
---|---|---|---|
Oral Presentation | 1 | M | Presentation - 15 minute max. Recorded and uploaded by students |
Assessment Rationale And Relationship
The written reports will test achievement of the stated intended knowledge and skills outcomes and ability to apply these skills to a specific case study.
Timetable
- Timetable Website: www.ncl.ac.uk/timetable/
- MMB8006's Timetable
Past Exam Papers
- Exam Papers Online : www.ncl.ac.uk/exam.papers/
- MMB8006's past Exam Papers
General Notes
N/A
Welcome to Newcastle University Module Catalogue
This is where you will be able to find all key information about modules on your programme of study. It will help you make an informed decision on the options available to you within your programme.
You may have some queries about the modules available to you. Your school office will be able to signpost you to someone who will support you with any queries.
Disclaimer
The information contained within the Module Catalogue relates to the 2024 academic year.
In accordance with University Terms and Conditions, the University makes all reasonable efforts to deliver the modules as described.
Modules may be amended on an annual basis to take account of changing staff expertise, developments in the discipline, the requirements of external bodies and partners, and student feedback. Module information for the 2025/26 entry will be published here in early-April 2025. Queries about information in the Module Catalogue should in the first instance be addressed to your School Office.